Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Nike's Heavy Discounts Take a Bite Out of Profits
Nike's latest earnings blew past Wall Street expectations, despite excess inventory taking a bite out of profits and disappointing sales in China.
TikTok Rolls Out New Guidelines Restricting 'Deepfakes'
TikTok is banning deepfakes amid increasing pressure from the U.S. government over privacy and security concerns. CEO Shou Zi Chew announced the policy in a TikTok video on Tuesday two days ahead of his scheduled appearance before congress.
The Day Ahead: Fed Rate Hike Decision and More Earnings
Cheddar News looks ahead to The Day Ahead as the Federal Reserve meets to decide on a rate hike. Earnings are also on tap from Petco, Chewy and KB Home.
Duolingo Taps ChatGPT to Provide Users With Personalized Feedback
Language app Duolingo last week launched a new subscription tier, called Duolingo Max, that uses an artificially intelligent chatbot to provide more personalized feedback to learners.
Moody's Upgrades Tesla Credit Rating
Moody's upgraded Tesla's credit ratings, citing its leadership in the EV market.
Morgan Stanley Bullish On Meta, Citing Cost-Cutting
Morgan Stanley has upgraded Meta to 'overweight' from an 'equal weight' as the social media giant continues to cut costs.
Netflix Taps 'Avengers: End Game' Team to Produce Potential Franchise Film
Netflix Taps 'Avengers: End Game' Team to Produce Potential Franchise Film
Foot Locker to Close 400 Mall-Based Stores By 2026
Foot Locker plans to close about 400 mall-based stores by 2026 as it looks to focus on its young shoppers with new concepts.
TikTok Sees Massive Growth Amid Ban Efforts
Despite efforts to ban the social media giant in the U.S., TikTok reported 150 million active monthly users.
